HIROYUKI KITANO

Last Updated :2024/04/03

Affiliations, Positions
Hiroshima University Hospital, Assistant Professor
E-mail
tanokinhiroshima-u.ac.jp

Basic Information

Major Professional Backgrounds

  • 2005/04, 2007/03, Chugoku Rosai Hospital, Clinical Resident
  • 2007/04/01, 2008/03/31, Hiroshima University Hospital, Clinical Fellow
  • 2008/04, 2011/03, Matsuyama Red Cross Hospital
  • 2011/04, 2013/03, Nakatsu Daiichi Hospital
  • 2013/04/01, 2017/03/31, Hiroshima University Hospital, Clinical Fellow
  • 2017/04/01, Hiroshima University Hospital, Assistant Professor

Educational Backgrounds

  • The University of Tokushima, Japan, 1999/04, 2005/03
  • Hiroshima University, 2013/04, 2017/08

Academic Degrees

  • Hiroshima University
  • Hiroshima University

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical surgery;Urology
  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Infectious disease medicine

Affiliated Academic Societies

Educational Activity

Course in Charge

  1. 2024, Undergraduate Education, Year, Clinical diagnosis and treatment II
  2. 2024, Undergraduate Education, Year, Systemic Disease Control
  3. 2024, Undergraduate Education, Intensive, Practice of Medicine I

Research Activities

Academic Papers

  1. The impact of change in serum C-reactive protein level on the prediction of effects of molecular targeted therapy in patients with metastatic renal cell carcinoma., BJU International, 117(6B), E67-74, 201601
  2. Impact of neutrophil-to-lymphocyte ratio on effects of targeted therapy for metastatic renal cell carcinoma patients with extrapulmonary metastasis, CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 11(5), E207-E214, 201705
    Link to Paper Search Results by DOI
  3. Combination therapy using molecular-targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma, CANCER MEDICINE, 6(10), 2308-2320, 201710
    Link to Paper Search Results by DOI
  4. Serous adenocarcinoma of retroperitoneum: a case report, INTERNATIONAL CANCER CONFERENCE JOURNAL, 6(4), 154-157, 201710
    Link to Paper Search Results by DOI
  5. Current status of countermeasures for infectious diseases and resistant microbes in the field of urology, INTERNATIONAL JOURNAL OF UROLOGY, 26(12), 1090-1098, 201912
    Link to Paper Search Results by DOI
  6. Magnetic resonance imaging/transrectal ultrasonography fusion targeted prostate biopsy finds more significant prostate cancer in biopsy-naive Japanese men compared with the standard biopsy, INTERNATIONAL JOURNAL OF UROLOGY, 27(2), 140-146, 202002
    Link to Paper Search Results by DOI
  7. Impact of radiological morphology of clinical T1 renal cell carcinoma on the prediction of upstaging to pathological T3, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 50(4), 473-478, 202004
    Link to Paper Search Results by DOI
  8. Renal metastasis from primary hepatocellular carcinoma: a case report, INTERNATIONAL CANCER CONFERENCE JOURNAL, 9(3), 141-145, 202007
    Link to Paper Search Results by DOI
  9. Indwelling catheterization, renal stones, and hydronephrosis are risk factors for symptomatic Staphylococcus aureus-related urinary tract infection., World Journal of Urology, 202003
  10. Primary adenocarcinoma of the rete testis with elevated serum CA19-9 antigen levels., International Cancer Conference Journal, 9(4), 240-243, 202008
  11. Developing New Information Sheets for Evacuees and Evacuation Centers to be Used During All Natural Disaster Phases, prehospital disaster medicine, 15, 1-5, 202009
  12. LAPAROSCOPIC RADICAL PROSTATECTOMY OF 926 PATIENTS AT THE HIROSHIMA ENDOUROLOGICAL ASSOCIATION, Nihon Hinyokika Gakkai Zasshi, 110(1), 1-11, 2019
  13. Primary adenocarcinoma of the rete testis with elevated serum CA19-9 antigen levels, INTERNATIONAL CANCER CONFERENCE JOURNAL, 9(4), 240-243, 202010
    Link to Paper Search Results by DOI
  14. TUBB3 Is Associated with High-Grade Histology, Poor Prognosis, p53 Expression, and Cancer Stem Cell Markers in Clear Cell Renal Cell Carcinoma, ONCOLOGY, 98(10), 689-698, 202010
    Link to Paper Search Results by DOI
  15. Developing New Information Sheets for Evacuees and Evacuation Centers to be Used During All Natural Disaster Phases, PREHOSPITAL AND DISASTER MEDICINE, 35(6), 683-687, 202012
    Link to Paper Search Results by DOI
  16. Impact of postoperative acute kidney injury on predicting the upstaging of chronic kidney disease after robot-assisted partial nephrectomy, ASIAN JOURNAL OF ENDOSCOPIC SURGERY, 14(1), 50-56, 202101
    Link to Paper Search Results by DOI
  17. BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma, ONCOLOGY, 99(4), 240-250, 202103
    Link to Paper Search Results by DOI
  18. Complicated cutaneous leishmaniasis caused by an imported case of Leishmania tropica in Japan: a case report, TROPICAL MEDICINE AND HEALTH, 49(1), 20210306
    Link to Paper Search Results by DOI
  19. Nationwide surveillance of bacterial pathogens isolated from patients with acute uncomplicated cystitis in 2018: Conducted by the Japanese Research Group for Urinary Tract Infections (JRGU), JOURNAL OF INFECTION AND CHEMOTHERAPY, 27(8), 1169-1180, 202108
    Link to Paper Search Results by DOI
  20. TUBB3 is associated with PTEN, neuroendocrine differentiation, and castration resistance in prostate cancer, UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 39(6), 202106
    Link to Paper Search Results by DOI

Invited Lecture, Oral Presentation, Poster Presentation

  1. Combination therapy using molecular-targeted drugs inhibiting platelet-derived growth factor receptors in the tumor microenvirnment of renal cell carcinoma, Hiroyuki Kitano, 2016/11/26, Without Invitation, Japanese
  2. Combination therapy using molecular-targeted drugs inhibiting platelet-derived growth factor receptors in the tumor microenvirnment of renal cell carcinoma, Hiroyuki Kitano, AUA2016, 2016/05/10, Without Invitation, English, San Diego
    Related URL
  3. Regenerating islet-derived related protein 4 as a candidate of a novel biomarker in castration-resistant prostate cancer patients, Jun Teishima, Hiroyuki Kitano, AUA 2016, 2016/05/09, Without Invitation, English
  4. Combination therapy using molecular-targeted drugs inhibiting platelet-derived growth factor receptors in the tumor microenvirnment of renal cell carcinoma, Hiroyuki Kitano, 31st European Association Urology Congress2016 munich, 2016/03/12, Without Invitation, English, Munich

External Funds

Acceptance Results of Competitive Funds

  1. 2021, 2023
  2. KAKENHI(Grant-in-Aid for Young Scientists (B)), 2016, 2017
  3. KAKENHI(Grant-in-Aid for Young Scientists ), 2018, 2019
  4. 2017, 2017

Social Activities

History as Peer Reviews of Academic Papers

  1. 2020, Journal of Infection and chemothearpy, Others, 2
  2. 2019, Journal of Infection and chemothearpy, Others, 3
  3. 2018, Journal of Infection and chemothearpy, Others, 2